GROUNDBREAKING STUDY LAUNCHES

"Intermountain launches groundbreaking study using the PreTRM test to prevent preterm birth." Read more here

DOCTORS SPEAK OUT

"Women want good information. If a test predicts that they might have a preterm birth, they want to know."

PROTEOMIC INNOVATION

PreTRM Test Featured in Top-Tiered Scientific Journal as Example of Proteomic Test That Advances Patient Care. Read More

DOCTORS SPEAK OUT

"The value of the PreTRM test cannot be overestimated. We continue to deal with the vast majority of women who eventually go into preterm labor and deliver early with having absolutely no identifiable risk factors." Watch Dr. Shulman's video here

PROTEOMIC INNOVATION

“We developed a novel blood test to PREDICT, at an EARLY point in pregnancy, a woman’s individual risk of having a premature baby. We aim to achieve our vision of improving the health of newborns by enabling earlier, effective interventions that make a difference.” Dr. Greg Critchfield, CEO

DOCTORS SPEAK OUT

"With 1 in 10 women in the United States delivering prematurely, I believe every woman is an excellent candidate for the PreTRM test." Watch Dr. Mandel's video here

News

Sera Prognostics and Anthem, Inc. Announce Commercial Partnership Leveraging Innovative Biomarker Test to Reduce Risk of Preterm Birth

May 19, 2021-The PreTRM® Test Is Designed to Build a Foundation for Healthy Communities One Baby at a Time Read More >

EVALUATION OF HEALTH AND ECONOMIC BENEFIT OF THE PRETRM® TEST-AND-TREAT STRATEGY
TO IMPROVE MATERNAL AND INFANT HEALTH AMONG COMMERCIALLY INSURED IN THE US

May 18, 2021-Data presented at the ISPOR 2021 Conference illustrating clinical benefit as well as cost savings Read More >

Sera Prognostics Completes $100 Million Series E Financing

April 28, 2021-Several prominent healthcare-focused institutional investors fund Sera to expand commercialization of the PreTRM® Test. Read More >

WHO WE ARE

PROVIDING INDIVIDUALIZED RISK ASSESSMENT TO PREDICT AND MANAGE PREMATURE BIRTH, PREECLAMPSIA, AND OTHER PREGNANCY COMPLICATIONS

Sera Prognostics is dedicated to improve the lives of women and babies through individualized prenatal care.  Sera’s strategy is to deliver pivotal information to physicians to improve health and to improve the economics of healthcare delivery for pregnant women.  Our first test, the PreTRM® Test, focuses on the early prediction of preterm birth risk, one of the most serious pregnancy complications which affects almost one in ten pregnancies in the U.S. alone.

Early and accurate prediction of risk for pregnancy complications helps pregnant women and their doctors better understand risks and proactively address risks of adverse pregnancy outcomes.  Learn about the PreTRM® Test for Risk Management.